Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Case series:oral CSA0001
Sponsors
PLA General Hospital
Eligibility
Sex/Gender
All
Age
14 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) all patients with clearly diagnosed NCP who voluntarily receive treatment and do not participate in other clinical trials; (2) aged >=18 years, approved by the ethics committee, fully understand and sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) those who do not meet the above inclusion criteria; (2) pregnant and lactating women; (3) severe basic diseases of the liver (Child Pugh score >=C, AST > 5 times the upper limit); (4) serious renal damage basic diseases (estimated glomerular filtration rate <=30 ml/min / 1.73 m2, or is undergoing continuous renal replacement therapy, hemodialysis, peritoneal dialysis); (5) people who accepted any 2019 - nCoV experimental treatment within 30days prior to evaluation; (6) people who are allergic to lactococcus lactis or pharmaceutical excipients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| nuclear acid test of faeces;nuclear acid test of the upper respiratory tract;IgM;IgG;CT test of lung;glutamic oxalacetic transaminase;glutamic-pyruvic transaminase;total bilirubin;direct bilirubin;urea nitrogen;lactic dehydrogenase;creatinine;lymphocyte;C-reactive protein;procalcitonin;erythrocyte sedimentation rate; | — |
Countries
China
Contacts
Public ContactGang Sun
PLA General Hospital
Outcome results
None listed